Loans to directors, staff and platforms

Hong Kong IPO disclosure precedents · 55 companies, 55 items

Loans to or from directors, employees, shareholders or share incentive/ESOP platforms, including repurchase payments made on behalf of platforms and deposits with shareholders.

2024-09-27Prospectus
Zhejiang Taimei Medical Technology Co., Ltd.浙江太美医疗科技股份有限公司02576.HK

These loans were repayable on demand.

Financial Information · p. 426

All the outstanding balances have been settled as of December 31, 2021.

Financial Information · p. 426

Our Directors are of the view that each of the related party transactions set out in Note 34 to the Accountant’s Report in Appendix I to this prospectus was conducted in the ordinary course of business with normal commercial terms between the relevant parties.

Financial Information · p. 426
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-05-16Prospectus
Sunho Biologics, Inc.盛禾生物控股有限公司02898.HK

Our amounts due to a related party decreased from RMB63.6 million as of December 31, 2022 to nil as of December 31, 2023, primarily because (i) all outstanding loans from Nanjing Bode, amounting to RMB34.4 million, was repaid by us in December 2023; and (ii) Nanjing Bode has become an Independent Third Party since July 2023 and we reclassified the amounts due to Nanjing Bode of RMB60.3 million to trade and other payables as of December 31, 2023.

Financial Information · p. 439

As confirmed by our Directors, all outstanding non-trade payables to Nanjing Bode, amounting to RMB60.3 million as of December 31, 2023, will be fully settled before Listing, and we do not plan to have additional non-trade related party transactions in the future.

Financial Information · p. 439

Our Directors confirm that all material related party transactions during the Track Record Period were conducted on an arm’s length basis, and would not distort our results of operations over the Track Record Period or make our historical results over the Track Record Period not reflective of our expectations for our future performance.

Financial Information · p. 447
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-05-07Prospectus
Marketingforce Management Ltd迈富时管理有限公司02556.HK

We received certain loans from Mr. Liu Huan, a senior management of our Group, which amounted to RMB8.0 million, RMB35.5 million and nil as of December 31, 2021, 2022 and 2023, respectively.

Financial Information · p. 455

Such loans were all fully repaid within the same year.

Financial Information · p. 455

Our Directors are of the view that each of the related party transactions set out in Note 34 to the Accountants’ Report in Appendix I to this prospectus was conducted in the ordinary course of business and with normal commercial terms between the relevant parties.

Financial Information · p. 455
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-03-20Prospectus
Lianlian DigiTech Co., Ltd.连连数字科技股份有限公司02598.HK

In 2020, we provided the loan of RMB150.0 million to LianTong with a term of one year and an annual interest rate of 4.41%.

Financial Information · p. 447

Our loans to related parties are non-trade in nature and were settled as of September 30, 2023, excepting for a clearance network guarantee deposit of RMB140 thousand with LianTong.

Financial Information · p. 448

Our Directors are of the view that each of the related party transactions was conducted in the ordinary course of business on an arm’s-length basis and with normal commercial terms between the relevant parties.

Financial Information · p. 447
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-03-18Prospectus
Palasino Holdings Limited百乐皇宫控股有限公司02536.HK

Our loan to a related party represented the loan advanced to BC Mortgage, being a joint venture of our Controlling Shareholder.

Financial Information · p. 353

Such amount has been settled by way of novation from our Group to FEC UK and distribution of dividends by Palasino Group to FEC UK which has declared on 8 September 2023.

Financial Information · p. 375

Our Directors confirm that our transactions with the related parties during the Track Record Period were conducted on an arm's length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.

Financial Information · p. 376
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-03-12Prospectus
Qyuns Therapeutics Co., Ltd.江苏荃信生物医药股份有限公司02509.HK

In January 2021, we provided a short-term loan of RMB100.0 million to Taizhou Huawei Investment Ltd. (泰州華威投資有限公司) (“Taizhou Huawei”), a subsidiary of Taizhou Huacheng Medical Investment Group Co., Ltd. (泰州華誠醫學投資集團有限公司), with an expected yield at 7.0% per annum.

Financial Information · p. 504

All of our non-trade balances had been settled as of September 30, 2023. Our Directors are of the view that the transactions with related parties were conducted on an arm’s-length basis.

Financial Information · p. 505
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-02-29Prospectus
Lesi Group Limited乐思集团有限公司02540.HK

For the years ended 31 December 2020 and 2021, we received loans from Mr. Yu, Mr. Zhao and Ms. Shu as part of our working capital.

Financial Information · p. 305

All balances with these related parties are unsecured, interest-free and repayable on demand.

Financial Information · p. 304

The non-trade balances due to Mr. Zhao and due from Ka Lok BVI will be settled prior to the Listing.

Financial Information · p. 304
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-11-27Prospectus
Sino-Synergy Hydrogen Energy Technology (Jiaxing) Co., Ltd.国鸿氢能科技(嘉兴)股份有限公司09663.HK

Our Directors are of the view that each of the related party transactions set out in Note 39 of the Accountant's Report as Appendix I to this prospectus was conducted on an arm's length basis in the ordinary course of business and with normal commercial terms between the relevant parties.

Financial Information · p. 479

All of the related party balances as of 31 May 2023 were trade in nature.

Financial Information · p. 480

In addition, we made a loan of RMB5.0 million to Yikongtong Aerospace, a former joint venture of our Group to finance its day-to-day operations, and received interest income of RMB0.1 million for the year ended 31 December 2021.

Financial Information · p. 480
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-11-10Prospectus
Shanxi Installation Group Co., Ltd.山西省安装集团股份有限公司02520.HK

The purpose of provision of loans to its associates and former associates was mainly for financing some construction projects, which our Group also invested in through shareholders loan to the relevant project companies which the Company has equity interests in.

Financial Information · p. 559

In addition, the former associates are the indirect wholly-owned subsidiaries of Shanxi CIG as at December 31, 2020, 2021 and 2022 and June 30, 2023, of which Shanxi CIG has undertaken the balances of loans to former associates as at December 31, 2020, 2021 and 2022 and June 30, 2023 to compensate to the Group in full for any failure of repayment.

Financial Information · p. 560

Our Directors believe that each of the related-party transactions set out in note 49 in the Accountants' Report in Appendix I to this prospectus was conducted in the ordinary course of business on an arm's-length basis between the relevant parties and was entered into on normal commercial terms.

Financial Information · p. 578
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-10-16Prospectus
J&T Global Express Limited极兔速递环球有限公司01519.HK

During the Track Record Period, we entered into loans agreements with our related parties and third parties.

Financial Information · p. 379

We expect that substantially all the non-trade balances with related parties will be settled prior to Listing.

Financial Information · p. 379

Our Directors believe that the related party transactions were carried out on an arm’s length basis and will not distort our results during the Track Record Period or make such results not reflective of our future performance.

Financial Information · p. 401
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-09-28Prospectus
Luyuan Group Holding (Cayman) Limited绿源集团控股(开曼)有限公司02451.HK

The balances due from a related party represented the loan to Linyi Luyuan Real Estate Co., Ltd. (“Linyi Luyuan”) in 2019, which were secured by apartments and shops owned by Linyi Luyuan with an effective annual interest rate of 6%.

Financial Information · p. 381

As Linyi Luyuan has defaulted on the loan, we have initiated legal proceedings against it for the total outstanding amount of RMB15.0 million.

Financial Information · p. 381

As a result, the balance of loans to a related party as of December 31, 2022 of RMB11.0 million had been fully settled as of the Latest Practicable Date.

Financial Information · p. 381
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-06-30Prospectus
Keep Inc.03650.HK

In 2017, we provided an interest-free, unsecured loan amounting RMB3.0 million to one of the management with a term of one year, which was later extended to December 31, 2021. The loan was repaid during the year ended December 31, 2020.

Financial Information · p. 323

We repurchased certain Series E Preferred Shares held by an entity wholly owned and controlled by Mr. Wang Ning, our founder, chairman of the board of Directors and chief executive officer of our Company, for a total consideration of RMB22 million.

Financial Information · p. 323

Our Directors believe that our transactions with the related parties during the Track Record Period were conducted in the normal course of business and on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.

Financial Information · p. 323
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-06-28Prospectus
Wise Living Technology Co., Ltd慧居科技股份有限公司02481.HK

During the Track Record Period, amounts due from a related party was mainly attributable to the loan financing arrangement with Beijing Zhongchuang.

Financial Information · p. 532

During the Track Record Period, we entered into certain financing arrangements with (i) Beijing Zhongchuang and (ii) Shuangliang Technology.

Financial Information · p. 557

Note: The amounts advanced from a related party will be settled upon the Listing.

Financial Information · p. 556
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-05-31Prospectus
Cutia Therapeutics科笛集团02487.HK

We provided an eight-year unsecured and non-interest-bearing loan of RMB11,127,000 and a ten-year unsecured and non-interest-bearing loans of RMB12,847,000 to Ms. Zhang Lele in December 2021 and December 2022, respectively.

Financial Information · p. 426

We provided these loans as part of our efforts to retain and motivate employees and such loans are available to all eligible employees who are part of the Pre-IPO Equity Incentive Plan.

Financial Information · p. 426

The loans to related parties are non-trade in nature and will not be settled prior to Listing.

Financial Information · p. 426
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-04-17Prospectus
MedSci Healthcare Holdings Limited梅斯健康控股有限公司02415.HK

The RMB0.3 million due from related parties in 2020, 2021 and 2022 was non-trade in nature and represented loans to Shanghai Meiyue, one of our former employee equity incentive platforms.

Financial Information · p. 405

Our Directors are of the view that each of the related party transactions set out in Note 29 to the Accountants’ Report included in Appendix I to this Prospectus was conducted in the ordinary course of business on an arm’s length basis and with normal commercial terms between the relevant parties.

Financial Information · p. 416
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us